Oral administration of clostridium butyricum gkb7 ameliorates signs of osteoarthritis in rats

HIGHLIGHTS

  • who: Sunny Li-Yun Chang and colleagues from the Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan have published the Article: Oral Administration of Clostridium butyricum GKB7 Ameliorates Signs of Osteoarthritis in Rats, in the Journal: Cells 2022, 11, 2169. of /2022/
  • what: The study evaluated the therapeutic effects of a live probiotic strain Clostridium butyricum GKB7 administered for 6 weeks to rats with knee OA (KOA) induced by anterior cruciate ligament transection (ACLT) of the right knee. The authors demonstrate that a newly identified strain of C. butyricum (GKB7) ameliorates the progression . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?